IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma

被引：12

作者：

Wang, Zewei ^{[1
]}

Xu, Le ^{[2
]}

Chang, Yuan ^{[3
]}

Zhou, Lin ^{[3
]}

Fu, Hangcheng ^{[1
]}

Zhang, Weijuan ^{[4
]}

Yang, Yuanfeng ^{[3
]}

Xu, Jiejie ^{[1
]}

机构：

[1] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai, Peoples R China

[3] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China

[4] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China

来源：

TUMOR BIOLOGY | 2016年 / 37卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Clear-cell renal cell carcinoma; Interleukin-33; Prognostic biomarker; Overall survival; ACQUIRED-IMMUNITY; CANCER; EXPRESSION; INNATE; ST2; INTERLEUKIN-33; CONTRIBUTES; MACROPHAGES; CYTOKINE; PATHWAY;

D O I：

10.1007/s13277-016-4879-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The aim of this study was to evaluate the potential prognostic significance of interleukin-33 (IL-33) in patients with clear-cell renal cell carcinoma (ccRCC) after surgical resection. In this retrospective research, we enrolled 203 patients with ccRCC undergoing nephrectomy between 2003 and 2004 in a single institution. We recorded clinicopathologic features, overall survival (OS), and recurrence-free survival (RFS) and assessed IL-33 expression by immunohistochemical staining. On such bases, the correlations between IL-33 expression and clinicopathologic features and prognosis were evaluated. A high expression of IL-33 was significantly associated with advanced TNM stage and Fuhrman grade (p = 0.017 and p < 0.001, respectively) in patients with ccRCC. Moreover, multivariate analysis identified IL-33 as an independent prognostic factor of OS for patients with ccRCC after surgery (hazard ratio = 2.050; 95 % CI 1.223-3.447; p = 0.006). The incorporation of IL-33 into the TNM stage and Fuhrman grade might help to refine individual risk stratification. The IL-33 expression may serve as an independent negative predictor of survival for patients with ccRCC after surgery.

引用

页码：11127 / 11134

页数：8

共 50 条

[11] IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma [J].

Bai, Qi ;

Liu, Li ;

Xia, Yu ;

Wang, Jiajun ;

Xi, Wei ;

Qu, Yang ;

Xiong, Ying ;

Long, Qilai ;

Xu, Jiejie ;

Guo, Jianming .

ONCOTARGET, 2017, 8 (27) :44186-44194

[12] Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma [J].

Laba, Pingcuo ;

Wang, Jianfeng ;

Zhang, Jin .

BMC CANCER, 2018, 18

[13] Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma [J].

Qu, Yang ;

Liu, Li ;

Wang, Jiajun ;

Xi, Wei ;

Xia, Yu ;

Bai, Qi ;

Xiong, Ying ;

Long, Qilai ;

Xu, Jiejie ;

Guo, Jianming .

ONCOTARGET, 2016, 7 (51) :84775-84784

[14] High Expression of MRPL23 Is Associated with Poor Survival in Clear-Cell Renal Cell Carcinoma [J].

Podemska, Edyta ;

Borowczak, Jedrzej ;

Lukasik, Damian ;

Grzanka, Dariusz ;

Durslewicz, Justyna .

CANCERS, 2024, 16 (23)

[15] Guanylate-binding Protein 2 Expression Is Associated With Poor Survival and Malignancy in Clear-cell Renal Cell Carcinoma [J].

Liu, Qingyuan ;

Hoffman, Robert M. ;

Song, Jing ;

Miao, Shiqi ;

Zhang, Jindong ;

Ding, Degang ;

Wang, Delin .

ANTICANCER RESEARCH, 2022, 42 (05) :2341-2354

[16] Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection [J].

Fu, Qiang ;

Liu, Zheng ;

Pan, Deng ;

Zhang, Weijuan ;

Xu, Le ;

Zhu, Yu ;

Liu, Haiou ;

Xu, Jiejie .

CANCER SCIENCE, 2014, 105 (11) :1427-1434

[17] Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma [J].

Xia, Yu ;

Liu, Li ;

Xiong, Ying ;

Bai, Qi ;

Wang, Jiajun ;

Xi, Wei ;

Qu, Yang ;

Xu, Jiejie ;

Guo, Jianming .

CANCER SCIENCE, 2016, 107 (09) :1243-1249

[18] Identifying an Inversin as a Novel Prognostic Marker in Patients with Clear-Cell Renal Cell Carcinoma [J].

Urlic, Ivanka ;

Soljic, Violeta ;

Vukoja, Martina ;

Marijanovic, Inga ;

Kraljevic, Marija ;

Urlic, Marjan ;

Maric, Sara ;

Vukojevic, Katarina ;

Filipovic, Natalija .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)

[19] High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma [J].

Xu, Zhiying ;

Liu, Yidong ;

Yang, Yuanfeng ;

Wang, Jieti ;

Zhang, Guodong ;

Liu, Zheng ;

Fu, Hangcheng ;

Wang, Zewei ;

Liu, Haiou ;

Xu, Jiejie .

ONCOTARGET, 2017, 8 (05) :7548-7558

[20] Immunotherapy of Clear-Cell Renal-Cell Carcinoma [J].

Grigolo, Sophie ;

Filgueira, Luis .

CANCERS, 2024, 16 (11)

← 1 2 3 4 5 →